XIAP and ovarian carcinoma: Similarly, increased expression of the inhibitor of apoptosis BIRC4 (XIAP) could also contribute to oxaliplatin resistance and counteract the increased expression of the cell death execution caspases 6 and 7 in the platinum-resistant ovarian cancer cell lines.